Omadacycline tosylate is used as an antibacterial agent effective against a broad range of bacteria, including those resistant to other antibiotics. It is particularly applied in the treatment of community-acquired bacterial pneumonia and acute skin and skin structure infections. Due to its mechanism of action, which involves inhibiting bacterial protein synthesis, it remains active against many multidrug-resistant pathogens. Its oral and intravenous formulations allow for flexible use in both outpatient and hospital settings. It is also being explored for use in other infections caused by resistant organisms, including certain sexually transmitted infections and intracellular pathogens.